Okunaka, M., Furuoka, M., Wakabayashi, M., Furuya, H., Bando, H., Shitara, K., Nakayama, I. (2025). A randomized phase II clinical trial evaluating the safety and efficacy of initial dose adjustment of zolbetuximab plus chemotherapy in patients with HER2-negative and CLDN18.2-positive unresectable advanced or recurrent gastric, gastroesophageal junction cancer or esophageal adenocarcinoma (GENTLE-Z).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.tps504